Geron hopes to restart stem-cell study in 2010

November 2, 2009

Biotechnology company Geron Corp. said Friday it hopes to pave the way for restarting human studies on a potential stem-cell treatment for spinal cord injury by conducting additional preclinical studies. (Forbes)